The Covid-19 vaccine manufactured by the Serum Institute of India (SII) in
India had to be disposed of after 100 million doses had been produced.
India had to be disposed of after 100 million doses had been produced.
According to CEO Adar Poonawalla, the company ceased manufacturing
Covishield in December last year due to low demand.
The Vaxzevria vaccine from AstraZeneca has been produced locally by SII,
the biggest vaccine manufacturer in the world.
In India, Covishield makes up more than 90% of all dosages.
Over two billion doses of the Covid-19 vaccination have been given out in
India. According to the federal health ministry, more than 70% of Indians
have ingested at least two doses.
